Drug Shows Promise Against Autoimmune Disease Scleroderma
MONDAY, Oct. 10, 2022 (HealthDay News) — Researchers report early success with using an existing rheumatoid arthritis (RA) drug to treat systemic sclerosis, a rare but potentially devastating autoimmune condition. The disease, a subset of scleroderma, hardens the skin and affects internal organs, but no approved treatment for it exists.Continue Reading